SARS-CoV-2 Outbreak Dynamics in an Isolated US Military Recruit Training Center With Rigorous Prevention Measures.


Journal

Epidemiology (Cambridge, Mass.)
ISSN: 1531-5487
Titre abrégé: Epidemiology
Pays: United States
ID NLM: 9009644

Informations de publication

Date de publication:
01 11 2022
Historique:
pubmed: 10 8 2022
medline: 14 10 2022
entrez: 9 8 2022
Statut: ppublish

Résumé

Marine recruits training at Parris Island experienced an unexpectedly high rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, despite preventive measures including a supervised, 2-week, pre-entry quarantine. We characterize SARS-CoV-2 transmission in this cohort. Between May and November 2020, we monitored 2,469 unvaccinated, mostly male, Marine recruits prospectively during basic training. If participants tested negative for SARS-CoV-2 by quantitative polymerase chain reaction (qPCR) at the end of quarantine, they were transferred to the training site in segregated companies and underwent biweekly testing for 6 weeks. We assessed the effects of coronavirus disease 2019 (COVID-19) prevention measures on other respiratory infections with passive surveillance data, performed phylogenetic analysis, and modeled transmission dynamics and testing regimens. Preventive measures were associated with drastically lower rates of other respiratory illnesses. However, among the trainees, 1,107 (44.8%) tested SARS-CoV-2-positive, with either mild or no symptoms. Phylogenetic analysis of viral genomes from 580 participants revealed that all cases but one were linked to five independent introductions, each characterized by accumulation of mutations across and within companies, and similar viral isolates in individuals from the same company. Variation in company transmission rates (mean reproduction number R 0 ; 5.5 [95% confidence interval [CI], 5.0, 6.1]) could be accounted for by multiple initial cases within a company and superspreader events. Simulations indicate that frequent rapid-report testing with case isolation may minimize outbreaks. Transmission of wild-type SARS-CoV-2 among Marine recruits was approximately twice that seen in the community. Insights from SARS-CoV-2 outbreak dynamics and mutations spread in a remote, congregate setting may inform effective mitigation strategies.

Sections du résumé

BACKGROUND
Marine recruits training at Parris Island experienced an unexpectedly high rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, despite preventive measures including a supervised, 2-week, pre-entry quarantine. We characterize SARS-CoV-2 transmission in this cohort.
METHODS
Between May and November 2020, we monitored 2,469 unvaccinated, mostly male, Marine recruits prospectively during basic training. If participants tested negative for SARS-CoV-2 by quantitative polymerase chain reaction (qPCR) at the end of quarantine, they were transferred to the training site in segregated companies and underwent biweekly testing for 6 weeks. We assessed the effects of coronavirus disease 2019 (COVID-19) prevention measures on other respiratory infections with passive surveillance data, performed phylogenetic analysis, and modeled transmission dynamics and testing regimens.
RESULTS
Preventive measures were associated with drastically lower rates of other respiratory illnesses. However, among the trainees, 1,107 (44.8%) tested SARS-CoV-2-positive, with either mild or no symptoms. Phylogenetic analysis of viral genomes from 580 participants revealed that all cases but one were linked to five independent introductions, each characterized by accumulation of mutations across and within companies, and similar viral isolates in individuals from the same company. Variation in company transmission rates (mean reproduction number R 0 ; 5.5 [95% confidence interval [CI], 5.0, 6.1]) could be accounted for by multiple initial cases within a company and superspreader events. Simulations indicate that frequent rapid-report testing with case isolation may minimize outbreaks.
CONCLUSIONS
Transmission of wild-type SARS-CoV-2 among Marine recruits was approximately twice that seen in the community. Insights from SARS-CoV-2 outbreak dynamics and mutations spread in a remote, congregate setting may inform effective mitigation strategies.

Identifiants

pubmed: 35944149
doi: 10.1097/EDE.0000000000001523
pii: 00001648-202211000-00005
pmc: PMC9531985
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

797-807

Subventions

Organisme : NIH HHS
ID : S10 OD018522
Pays : United States
Organisme : NIH HHS
ID : S10 OD026880
Pays : United States

Informations de copyright

Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.

Références

Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069.
Han D, Li R, Han Y, Zhang R, Li J. COVID-19: insight into the asymptomatic SARS-COV-2 infection and transmission. Int J Biol Sci. 2020;16:2803–2811.
Johansson MA, Quandelacy TM, Kada S, et al. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw Open. 2021;4:e2035057.
Sah P, Fitzpatrick MC, Zimmer CF, et al. Asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis. Proc Natl Acad Sci U S A. 2021;118:e2109229118.
McMichael TM, Clark S, Pogosjans S, et al.; Public Health – Seattle & King County, EvergreenHealth, and CDC COVID-19 Investigation Team. COVID-19 in a long-term care facility - King County, Washington, February 27-March 9, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:339–342.
Roxby AC, Greninger AL, Hatfield KM, et al. Outbreak investigation of COVID-19 among residents and staff of an independent and assisted living community for older adults in Seattle, Washington. JAMA Intern Med. 2020;180:1101–1105.
James A, Eagle L, Phillips C, et al. High COVID-19 attack rate among attendees at events at a Church - Arkansas, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:632–635.
Moriarty LF, Plucinski MM, Marston BJ, et al.; CDC Cruise Ship Response Team; California Department of Public Health COVID-19 Team; Solano County COVID-19 Team. Public health responses to COVID-19 outbreaks on cruise ships - worldwide, February-March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:347–352.
Hagan LM, Williams SP, Spaulding AC, et al. Mass testing for SARS-CoV-2 in 16 prisons and jails - six jurisdictions, United States, April-May 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1139–1143.
Njuguna H, Wallace M, Simonson S, et al. Serial laboratory testing for SARS-CoV-2 infection among incarcerated and detained persons in a correctional and detention facility - Louisiana, April-May 2020. MMWR Morb Mortal Wkly Rep. 2020;69:836–840.
Baettig SJ, Parini A, Cardona I, Morand GB. Case series of coronavirus (SARS-CoV-2) in a military recruit school: clinical, sanitary and logistical implications. BMJ Mil Health. 2021;167:251–254.
Crameri GAG, Bielecki M, Züst R, Buehrer TW, Stanga Z, Deuel JW. Reduced maximal aerobic capacity after COVID-19 in young adult recruits, Switzerland, May 2020. Euro Surveill. 2020;25:2001542.
Kasper MR, Geibe JR, Sears CL, et al. An outbreak of Covid-19 on an aircraft carrier. N Engl J Med. 2020;383:2417–2426.
Letizia AG, Ramos I, Obla A, et al. SARS-CoV-2 transmission among marine recruits during quarantine. N Engl J Med. 2020;383:2407–2416.
Michael NL. SARS-CoV-2 in the U.S. military - lessons for civil society. N Engl J Med. 2020;383:2472–2473.
Pirnay JP, Selhorst P, Cochez C, et al. Study of a SARS-CoV-2 outbreak in a Belgian military education and training center in Maradi, Niger. Viruses. 2020;12:949.
Talmy T, Tsur A, Shabtay O. Duration of SARS-CoV-2 detection in Israel Defense Forces soldiers with mild COVID-19. J Med Virol. 2021;93:608–610.
Ramos I, Goforth C, Soares-Schanoski A, et al. Antibody responses to SARS-CoV-2 following an outbreak among marine recruits with asymptomatic or mild infection. Front Immunol. 2021;12:681586.
Liu Y, Morgenstern C, Kelly J, Lowe R, Jit M; CMMID COVID-19 Working Group. The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories. BMC Med. 2021;19:40.
Marcus JE, Frankel DN, Pawlak MT, et al. COVID-19 monitoring and response among U.S. Air Force Basic Military Trainees - Texas, March-April 2020. MMWR Morb Mortal Wkly Rep. 2020;69:685–688.
Letizia AG, Ge Y, Vangeti S, et al. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study. Lancet Respir Med. 2021;9:712–720.
McNeil JC, Flores AR, Kaplan SL, Hulten KG. The indirect impact of the SARS-CoV-2 pandemic on invasive group A Streptococcus, Streptococcus pneumoniae and Staphylococcus aureus infections in Houston area children. Pediatr Infect Dis J. 2021;40:e313–e316.
Nagakubo Y, Hirotsu Y, Maejima M, et al. Non-pharmaceutical interventions during the COVID-19 epidemic changed detection rates of other circulating respiratory pathogens in Japan. PLoS One. 2022;17:e0262874.
Tanislav C, Kostev K. Fewer non-COVID-19 respiratory tract infections and gastrointestinal infections during the COVID-19 pandemic. J Med Virol. 2022;94:298–302.
Stewart JN. DoD Instruction 6490.03, “Deployment Health.” 2019. Available at: https://www.esd.whs.mil/Portals/54/Documents/DD/issuances/dodi/649003p.pdf . Accessed June 19, 2019.
Bandelt HJ, Forster P, Röhl A. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol. 1999;16:37–48.
Leigh JW, Bryant D. POPART: full-feature software for haplotype network construction. Methods Ecol Evol. 2015;6:1110–1116.
Lavezzo E, Franchin E, Ciavarella C, et al.; Imperial College COVID-19 Response Team; Imperial College COVID-19 Response Team. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’. Nature. 2020;584:425–429.
Carpenter B, Gelman A, Hoffman MD, et al. Stan: a probabilistic programming language. J Stat Softw. 2017;76:32.
Liu Y, Rocklov J. The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus. J Travel Med. 2021;28:taab124.
Endo A, Abbott S, Kucharski AJ, et al.; Centre for the Mathematical Modelling of Infectious Diseases. Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China. Wellcome Open Res. 2020;5:67.
Svensson A. A note on generation times in epidemic models. Math Biosci. 2007;208:300–311.
Kak V. Infections in confined spaces: cruise ships, military barracks, and college dormitories. Infect Dis Clin North Am. 2007;21:773–784, ix–x.
Lee T, Jordan NN, Sanchez JL, Gaydos JC. Selected nonvaccine interventions to prevent infectious acute respiratory disease. Am J Prev Med. 2005;28:305–316.
Petersen E, Koopmans M, Go U, et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis. 2020;20:e238–e244.
Gray GC, Callahan JD, Hawksworth AW, Fisher CA, Gaydos JC. Respiratory diseases among U.S. military personnel: countering emerging threats. Emerg Infect Dis. 1999;5:379–385.
Pettirosso E, Giles M, Cole S, Rees M. COVID-19 and pregnancy: a review of clinical characteristics, obstetric outcomes and vertical transmission. Aust N Z J Obstet Gynaecol. 2020;60:640–659.
Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med. 2020;173:262–267.
Mina MJ, Peto TE, García-Fiñana M, Semple MG, Buchan IE. Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19. Lancet. 2021;397:1425–1427.

Auteurs

Rhonda A Lizewski (RA)

From the Naval Medical Research Unit SIX, Lima, Peru.

Rachel S G Sealfon (RSG)

Center for Computational Biology, Flatiron Institute, Simons Foundation, New York, NY.

Sang Woo Park (SW)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ.

Gregory R Smith (GR)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY.

Chad K Porter (CK)

Naval Medical Research Center, Silver Spring, MD.

Ana S Gonzalez-Reiche (AS)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.

Yongchao Ge (Y)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY.

Clare M Miller (CM)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY.

Carl W Goforth (CW)

Naval Medical Research Center, Silver Spring, MD.

Hanna Pincas (H)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY.

Michael S Termini (MS)

Navy Medicine Readiness and Training Command Beaufort, Beaufort, SC.

Irene Ramos (I)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY.

Venugopalan D Nair (VD)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY.

Stephen E Lizewski (SE)

From the Naval Medical Research Unit SIX, Lima, Peru.

Hala Alshammary (H)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY.

Regina Z Cer (RZ)

Genomics & Bioinformatics Department, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Fort Detrick, MD.

Hua Wei Chen (HW)

Naval Medical Research Center, Silver Spring, MD.
Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD.

Mary-Catherine George (MC)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY.

Catherine E Arnold (CE)

Genomics & Bioinformatics Department, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Fort Detrick, MD.
Defense Threat Reduction Agency, Fort Belvoir, VA.

Lindsay A Glang (LA)

Genomics & Bioinformatics Department, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Fort Detrick, MD.
Leidos, Reston, VA.

Kyle A Long (KA)

Genomics & Bioinformatics Department, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Fort Detrick, MD.
Leidos, Reston, VA.

Francisco Malagon (F)

Genomics & Bioinformatics Department, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Fort Detrick, MD.
Leidos, Reston, VA.

Jan J Marayag (JJ)

Naval Medical Research Center, Silver Spring, MD.

Edgar Nunez (E)

Naval Medical Research Center, Silver Spring, MD.

Gregory K Rice (GK)

Genomics & Bioinformatics Department, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Fort Detrick, MD.
Leidos, Reston, VA.

Ernesto Santa Ana (E)

Naval Medical Research Center, Silver Spring, MD.

Megan A Schilling (MA)

Naval Medical Research Center, Silver Spring, MD.

Darci R Smith (DR)

Immunodiagnostics Department, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Fort Detrick, MD.

Victor A Sugiharto (VA)

Naval Medical Research Center, Silver Spring, MD.
Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD.

Peifang Sun (P)

Naval Medical Research Center, Silver Spring, MD.

Adriana van de Guchte (A)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.

Zenab Khan (Z)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.

Jayeeta Dutta (J)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.

Sindhu Vangeti (S)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY.

Logan J Voegtly (LJ)

Genomics & Bioinformatics Department, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Fort Detrick, MD.
Leidos, Reston, VA.

Dawn L Weir (DL)

Naval Medical Research Center, Silver Spring, MD.

C Jessica E Metcalf (CJE)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ.

Olga G Troyanskaya (OG)

Center for Computational Biology, Flatiron Institute, Simons Foundation, New York, NY.
Department of Computer Science, Princeton University, Princeton, NJ.
Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ.

Kimberly A Bishop-Lilly (KA)

Genomics & Bioinformatics Department, Biological Defense Research Directorate, Naval Medical Research Center-Frederick, Fort Detrick, MD.

Bryan T Grenfell (BT)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ.

Harm van Bakel (H)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.

Andrew G Letizia (AG)

Naval Medical Research Center, Silver Spring, MD.

Stuart C Sealfon (SC)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH